GRK4_HUMAN - dbPTM
GRK4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GRK4_HUMAN
UniProt AC P32298
Protein Name G protein-coupled receptor kinase 4
Gene Name GRK4
Organism Homo sapiens (Human).
Sequence Length 578
Subcellular Localization Cytoplasm. Cytoplasm, cell cortex. Both at the cell surface and dispersed in the cytoplasm under basal conditions. Receptor stimulation results in the internalization of GRK4 to the perinuclear area, where colocalization with DRD3 is observed strongl
Protein Description Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2..
Protein Sequence MELENIVANSLLLKARQGGYGKKSGRSKKWKEILTLPPVSQCSELRHSIEKDYSSLCDKQPIGRRLFRQFCDTKPTLKRHIEFLDAVAEYEVADDEDRSDCGLSILDRFFNDKLAAPLPEIPPDVVTECRLGLKEENPSKKAFEECTRVAHNYLRGEPFEEYQESSYFSQFLQWKWLERQPVTKNTFRHYRVLGKGGFGEVCACQVRATGKMYACKKLQKKRIKKRKGEAMALNEKRILEKVQSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNLGNPGFDEQRAVFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLATEIPEGQRVRGRVGTVGYMAPEVVNNEKYTFSPDWWGLGCLIYEMIQGHSPFKKYKEKVKWEEVDQRIKNDTEEYSEKFSEDAKSICRMLLTKNPSKRLGCRGEGAAGVKQHPVFKDINFRRLEANMLEPPFCPDPHAVYCKDVLDIEQFSVVKGIYLDTADEDFYARFATGCVSIPWQNEMIESGCFKDINKSESEEALPLDLDKNIHTPVSRPNRGFFYRLFRRGGCLTMVPSEKEVEPKQC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MELENIVA
-------CCHHHHHH
13.8022223895
5Ubiquitination---MELENIVANSLL
---CCHHHHHHHHHH
46.8121890473
6Ubiquitination--MELENIVANSLLL
--CCHHHHHHHHHHH
1.9521890473
10PhosphorylationLENIVANSLLLKARQ
HHHHHHHHHHHHHHC
15.62-
14UbiquitinationVANSLLLKARQGGYG
HHHHHHHHHHCCCCC
41.30-
22UbiquitinationARQGGYGKKSGRSKK
HHCCCCCCCCCCCCC
34.9721890473
23UbiquitinationRQGGYGKKSGRSKKW
HCCCCCCCCCCCCCH
54.5021890473
24PhosphorylationQGGYGKKSGRSKKWK
CCCCCCCCCCCCCHH
42.81-
48PhosphorylationQCSELRHSIEKDYSS
HHHHHHHHHHHCHHH
26.4726437602
90PhosphorylationFLDAVAEYEVADDED
HHHHHHEEEECCCCC
13.1322210691
104PhosphorylationDRSDCGLSILDRFFN
CCCCCCHHHHHHHHC
13.3424719451
139PhosphorylationGLKEENPSKKAFEEC
CCCCCCCCHHHHHHH
59.3729083192
147PhosphorylationKKAFEECTRVAHNYL
HHHHHHHHHHHHHHH
31.3029083192
184 (in isoform 3)Ubiquitination-54.9821890473
184 (in isoform 2)Ubiquitination-54.9821890473
184UbiquitinationLERQPVTKNTFRHYR
HHCCCCCCCCEEEEE
54.9821890473
185 (in isoform 2)Ubiquitination-34.7721890473
185UbiquitinationERQPVTKNTFRHYRV
HCCCCCCCCEEEEEE
34.7721890473
185 (in isoform 3)Ubiquitination-34.7721890473
195UbiquitinationRHYRVLGKGGFGEVC
EEEEECCCCCCCCCC
52.26-
195AcetylationRHYRVLGKGGFGEVC
EEEEECCCCCCCCCC
52.2620167786
211UbiquitinationCQVRATGKMYACKKL
EEEECCCCCHHHHHH
25.12-
216 (in isoform 1)Ubiquitination-48.6321890473
216 (in isoform 4)Ubiquitination-48.6321890473
216UbiquitinationTGKMYACKKLQKKRI
CCCCHHHHHHHHHHH
48.6321890473
217 (in isoform 4)Ubiquitination-56.9121890473
217 (in isoform 1)Ubiquitination-56.9121890473
217UbiquitinationGKMYACKKLQKKRIK
CCCHHHHHHHHHHHH
56.9121890473
223UbiquitinationKKLQKKRIKKRKGEA
HHHHHHHHHHHHHHH
9.4121890473
224UbiquitinationKLQKKRIKKRKGEAM
HHHHHHHHHHHHHHH
51.0321890473
227UbiquitinationKKRIKKRKGEAMALN
HHHHHHHHHHHHHHC
70.72-
229UbiquitinationRIKKRKGEAMALNEK
HHHHHHHHHHHHCHH
38.0021890473
230UbiquitinationIKKRKGEAMALNEKR
HHHHHHHHHHHCHHH
9.3821890473
244PhosphorylationRILEKVQSRFVVSLA
HHHHHHHHHHHHHHH
30.58-
249PhosphorylationVQSRFVVSLAYAYET
HHHHHHHHHHHHHHC
11.28-
255UbiquitinationVSLAYAYETKDALCL
HHHHHHHHCCCEEEE
41.0121890473
256UbiquitinationSLAYAYETKDALCLV
HHHHHHHCCCEEEEE
22.8821890473
256PhosphorylationSLAYAYETKDALCLV
HHHHHHHCCCEEEEE
22.88-
409PhosphorylationIKNDTEEYSEKFSED
HHCCHHHHHHHHHHH
18.85-
419PhosphorylationKFSEDAKSICRMLLT
HHHHHHHHHHHHHHH
28.74-
426PhosphorylationSICRMLLTKNPSKRL
HHHHHHHHCCHHHCC
25.47-
430PhosphorylationMLLTKNPSKRLGCRG
HHHHCCHHHCCCCCC
39.54-
485PhosphorylationVLDIEQFSVVKGIYL
CCCHHHHEEEEEEEE
26.20-
527AcetylationGCFKDINKSESEEAL
CCCCCCCCCCCCCCC
56.807307297
528PhosphorylationCFKDINKSESEEALP
CCCCCCCCCCCCCCC
41.7030622161
530PhosphorylationKDINKSESEEALPLD
CCCCCCCCCCCCCCC
48.0730622161

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
10SPhosphorylationKinaseGRK4P32298
PSP
139SPhosphorylationKinaseGRK4P32298
PSP
244SPhosphorylationKinaseGRK4P32298
PSP
249SPhosphorylationKinaseGRK4P32298
PSP
256TPhosphorylationKinaseGRK4P32298
PSP
419SPhosphorylationKinaseGRK4P32298
PSP
426TPhosphorylationKinaseGRK4P32298
PSP
430SPhosphorylationKinaseGRK4P32298
PSP
485SPhosphorylationKinaseGRK4P32298
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GRK4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GRK4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FSHR_HUMANFSHRphysical
10379886

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GRK4_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP